News
FDA approves blood test to detect Alzheimer’s disease
The test has a complicated name: The Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio. But the goal of the test, created by Fujirebio Diagnostics, is simple: Early detection of beta-amyloid plaques linked to the neurocognitive disease in adults 55 and older who are exhibiting signs and symptoms of the disorder.
Experts say the test could dramatically improve access to earlier, more accurate diagnoses, particularly for older Americans ...
Alzheimer’s is the seventh-leading cause of death among US adults, with the average patient living four to eight years after diagnosis.
In a statement posted by the Massachusetts Institute of Technology Monday, researchers said they have used data about fruit ...
A new UVA study finds that HIV drugs like NRTIs may reduce Alzheimer's risk by 10% annually, suggesting potential for ...
Symptomatic infection with the virus responsible for cold sores around the mouth–herpes simplex 1, or HSV-1 for short—may ...
The very first blood test for Alzheimer's disease detection has been green-lit by the US Food and Drug Administration (FDA), ...
The Food and Drug Administration has cleared the blood test to help diagnose Alzheimer's disease, potentially making it ...
While most people associate Alzheimer's symptoms with old age, new research suggests signs could begin to show up in your 20s ...
As researchers work to improve treatment of Alzheimer's disease, new research by UCLA Health identified a candidate drug that reduces levels of a toxic form of a protein in the brain caused by the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback